The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  H. Madhyastha,et al.  NFκB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  G. Kristiansen,et al.  Periostin is up-regulated in high grade and high stage prostate cancer , 2010, BMC Cancer.

[4]  G. Kristiansen,et al.  Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancer. , 2010, Histology and histopathology.

[5]  G. Kristiansen,et al.  Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha‐methylacyl‐CoA racemase (AMACR) as prostatic cancer tissue marker , 2010, Histopathology.

[6]  F. Alkuraya,et al.  Mutation of CANT1 causes Desbuquois dysplasia , 2010, American journal of medical genetics. Part A.

[7]  A. Munnich,et al.  Identification of CANT1 mutations in Desbuquois dysplasia. , 2009, American journal of human genetics.

[8]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[9]  Han-Ming Shen,et al.  NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy , 2009, Apoptosis.

[10]  S. Dhanasekaran,et al.  A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. , 2008, Cancer research.

[11]  C. Pilarsky,et al.  GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics , 2008, British Journal of Cancer.

[12]  P. Metrakos,et al.  Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer , 2008, Pharmacological Reviews.

[13]  G. Jenster,et al.  Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. , 2008, Cancer research.

[14]  R. Uzzo,et al.  Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone‐refractory prostate cancer , 2008, Cancer.

[15]  A. Alberti,et al.  APY-1, a novel Caenorhabditis elegans apyrase involved in unfolded protein response signalling and stress responses. , 2008, Molecular biology of the cell.

[16]  E. Campo,et al.  Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse , 2005, British Journal of Cancer.

[17]  Andreas Nitsche,et al.  Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? , 2005, Journal of Molecular Medicine.

[18]  Christian Pilarsky,et al.  Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival , 2005, The Journal of pathology.

[19]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. , 2004, The New England journal of medicine.

[20]  C. Tangen,et al.  Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.

[21]  E. Schwarz,et al.  NFκB: A Pivotal Transcription Factor in Prostate Cancer Metastasis to Bone , 2003, Clinical orthopaedics and related research.

[22]  W. Schulz,et al.  Molecular biology of prostate cancer. , 2003, Molecular human reproduction.

[23]  S. Sugano,et al.  Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways , 2003, Oncogene.

[24]  A. Munnich,et al.  Homozygosity mapping of a Desbuquois dysplasia locus to chromosome 17q25.3 , 2003, Journal of medical genetics.

[25]  D. Murphy,et al.  Bacterial expression and characterization of a novel, soluble, calcium-binding, and calcium-activated human nucleotidase. , 2003, Biochemistry.

[26]  H. Zimmermann,et al.  Cloning, Expression, and Functional Characterization of a Ca2+-dependent Endoplasmic Reticulum Nucleoside Diphosphatase* , 2002, The Journal of Biological Chemistry.

[27]  Thomas M. Smith,et al.  Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases. , 2002, Archives of biochemistry and biophysics.

[28]  R. Kladney,et al.  GP73, a novel Golgi-localized protein upregulated by viral infection , 2000, Gene.

[29]  R. Autorino,et al.  Hormone-Refractory Prostate Cancer , 2012, Drugs.